Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H30N2O3.ClH |
| Molecular Weight | 406.946 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC(CC(=O)NCCCC2=CC=C(C)C(C)=C2)=CC=C1OCCN
InChI
InChIKey=OUEKLNJUMVZULZ-UHFFFAOYSA-N
InChI=1S/C22H30N2O3.ClH/c1-16-6-7-18(13-17(16)2)5-4-11-24-22(25)15-19-8-9-20(27-12-10-23)21(14-19)26-3;/h6-9,13-14H,4-5,10-12,15,23H2,1-3H3,(H,24,25);1H
Davasaicin is a synthetic derivative of capsaicin, developed at the Korea Research Institute of Chemical Technology. Davasaicin possesses very potent analgesic activity, demonstrated in several animal models, such as phenylbenzoquinone-induced writhing test, tail-flick test in mice and adjuvant arthritic flexion test in rats. When administered topically, davasaicin has an antipruritic effect in the mouse model.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
174661-97-3
Created by
admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025
|
PRIMARY | |||
|
51V6N8BA2P
Created by
admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025
|
PRIMARY | |||
|
177286
Created by
admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025
|
PRIMARY | |||
|
DTXSID40169887
Created by
admin on Mon Mar 31 21:49:05 GMT 2025 , Edited by admin on Mon Mar 31 21:49:05 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
